Cross-Talk Between Myoc P. Y437h Mutation And Tgf-Beta 2 In The Pathology Of Glaucoma

Yang Yang,Al Sabri Waled Abdulghani Abdulatef,LuSi Zhang,Haibo Jiang,Zhou Zeng,Haibo Li,Xiaobo Xia
DOI: https://doi.org/10.7150/ijms.43614
2020-01-01
International Journal of Medical Sciences
Abstract:Objective: To identify the interaction between the MYOC Y437H mutation and TGF-beta 2 in a family with primary open-angle glaucoma (POAG).Methods: The MYOC Y437H mutation was identified in a family with POAG; the family was a fourth-generation family with 27 members, of which 6 members were affected. Analysis focused on the secreted myocilin protein and TGF-beta 2 found in the aqueous humor. Samples were taken both from normal controls and MYOC mutant carriers and cross-talk between MYOC Y437H and TGF-beta 2 were evaluated in the trabecular meshwork (TM) cells.Results: Aqueous humor secreted myocilin protein levels were reduced while TGF-beta 2 levels were increased in patients with the MYOC (c.1309T>C) mutation. This inverse relationship indicated that elevated TGF-beta 2 may be an important pathogenic mechanism in the progression of myocilin-related POAG. In TM cells expressing the MYOC Y437H mutant, exogenous TGF-beta 2 also significantly increased myocilin expression as well as the endoplasmic reticulum (ER) stress markers GRP94 and CHOP. This increase in TGF-beta 2 was also associated with increased cell death in cells carrying the MYOC Y437H mutation.Conclusion: These data collectively suggest that the mutual interaction between glaucomatous MYOC mutation and TGF-beta 2 contributed to the cell death of TM cells. This relationship also provides a new, therapeutic targets for the treatment of glaucoma.
What problem does this paper attempt to address?